Breast cancer is the most common malignant tumor in women worldwide. Its early diagnosis relies on radiology and clinical evaluation, supplemented by biopsy confirmation. Technological advances in medical imaging, especially in the field of artificial intelligence, allow to address clinical challenges in cancer detection and classification, as well as in the assessment of treatment response, and in monitoring disease progression. Radiomics allows to extract features from images, related to tumor size, shape, intensity, and texture, providing comprehensive tumor characterization. In this paper, we briefly review some Radiomics approaches in breast cancer, focusing on the non-invasive distinction between in-situ and infiltrating breast tumors, and present a preliminary test using Radiomics signatures in DCE-MRI and machine learning, aimed to investigate the feasibility of distinguishing infiltrating cancer from ductal carcinoma in situ (DCIS) diagnosed by preoperative core needle biopsy.

Radiomics for the Discrimination of Infiltrative vs In Situ Breast Cancer

Benedetta Tafuri;Luana Conte
;
Giorgio De Nunzio
2019-01-01

Abstract

Breast cancer is the most common malignant tumor in women worldwide. Its early diagnosis relies on radiology and clinical evaluation, supplemented by biopsy confirmation. Technological advances in medical imaging, especially in the field of artificial intelligence, allow to address clinical challenges in cancer detection and classification, as well as in the assessment of treatment response, and in monitoring disease progression. Radiomics allows to extract features from images, related to tumor size, shape, intensity, and texture, providing comprehensive tumor characterization. In this paper, we briefly review some Radiomics approaches in breast cancer, focusing on the non-invasive distinction between in-situ and infiltrating breast tumors, and present a preliminary test using Radiomics signatures in DCE-MRI and machine learning, aimed to investigate the feasibility of distinguishing infiltrating cancer from ductal carcinoma in situ (DCIS) diagnosed by preoperative core needle biopsy.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11587/445785
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact